Overall Survival With Maintenance Olaparib at a 7-Year Follow-up in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial
- Resource Type
- Academic Journal
- Source
- Obstetrical & Gynecological Survey. Jan 01, 2023 78(1):25-27
- Subject
- Language
- English
- ISSN
- 0029-7828